Cite
HARVARD Citation
Fukudo, S. et al. (2017). Optimal dose of ramosetron in female patients with irritable bowel syndrome with diarrhea: A randomized, placebo‐controlled phase II study. Neurogastroenterology & motility. 29 (6), p. n/a. [Online].